Story
Florida Sues Pfizer Over COVID-19 Vaccine Safety and Efficacy Claims
Florida's Attorney General has filed a lawsuit against pharmaceutical giant Pfizer Inc. (PFE) and its CEO, Albert Bourla, accusing the company of making misleading claims about its COVID-19 vaccine. The legal action, filed in a Florida state court on Thursday, alleges violations of the state's consumer protection law.
Details of the Complaint
The lawsuit, brought forth by Attorney General James Uthmeier, alleges that Pfizer misrepresented the safety and effectiveness of its vaccine. According to the complaint, the company failed to adequately disclose potential risks, such as heart inflammation and other adverse events, while promoting the product as safe for consumers.
Florida's suit also claims Pfizer promoted the vaccine as a tool to protect others by preventing transmission, despite allegedly not having tested for this capability. The state further accuses the company of employing unfair market tactics to establish dominance, citing its more than $80 billion in vaccine sales and a subsequent price increase.
Key allegations in the lawsuit include:
Ad- Misrepresenting vaccine safety by concealing potential adverse events.
- Falsely claiming the vaccine would prevent virus transmission.
- Engaging in unfair practices to dominate the market.
- Increasing the vaccine price nearly fourfold from approximately $30 to a range of $110 to $130 per dose in 2023.
Financial Penalties and Market Impact
The state is seeking a court order to halt the alleged conduct, along with significant financial penalties. Florida has requested fines of $10,000 per violation, which could increase to $15,000 for violations involving seniors or disabled individuals. The lawsuit also seeks the return of profits Pfizer earned as a result of the alleged misconduct.
Following the news, shares of Pfizer traded approximately 1% lower on Thursday. The lawsuit introduces new legal and financial risks for the company, which has faced scrutiny over its vaccine business following the peak of the pandemic.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.
Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.
Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.
DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.